| |
| Magyar Szülészeti-Nőgyógyászati Ultrahang Társaság |
|
| 2010 CREOG & APGO Annual Meeting |
 Rendezvény kezdete: 2010.03.03. | Rendezvény vége: 2010.03.06. |
| Szakterület(ek): Belgyógyászat, Egészségügyi menedzsment, Gyógyszertan, klinikai farmakológia, Gasztroenterológia, Laboratóriumi medicina, Mikrobiológia, Orvosi informatika |
| Tudományos információ: Association of Professors of Gynecology and Obstetrics |
| Címe: USA, 2130 Priest Bridge Drive Crofton, MD, 21114 |
| E-mail: bfetsko@apgo.org |
| Szervező: Association of Professors of Gynecology and Obstetrics |
| Munkahely neve: Association of Professors of Gynecology and Obstetrics |
| Címe: USA, 2130 Priest Bridge Drive Crofton, MD, 21114 |
| E-mail: bfetsko@apgo.org |
| Helyszín: USA, Orlando, FL, |
| A rendezvény Web oldala: http://www.apgo.org/meetings/index.cfm/cat/annual%20meeting.htm |
|
|
 |
| |
| Magyar Kardiológusok Társasága |
|
| International Conference on Early Disease Detection and Prevention (EDDP) |
| Rendezvény kezdete: 2010.02.25. | Rendezvény vége: 2010.02.28. |
| Helyszín: Németország, München, |
| A rendezvény Web oldala: http://www.paragon-conventions.com/EDDP2010 |
This year's EDDP conference will focus on cardiovascular (cardiac disease and hypertension), metabolic (diabetes) and renal diseases. With a scientific program featuring a distinguished international panel of leading speakers, as well as a concurrent exhibition, this conference aims to:
Discuss all elements relevant to early detection of disease prior to its clinical appearance
Highlight the most updated technological and other means for disease prevention
Encourage a free exchange of ideas among high-caliber presenters and participants
Serve as a platform for the biotech/pharma industries to discuss ongoing projects and products
Present general principles, ongoing academic/industrial research, and the latest achievements in the field
Highlight biotechnological innovations and evaluate their applicability and cost-effectiveness
Set the stage for prevention of disease by pharmacological, genetic or other interventional modalities |
|
|
|
